Business Description
Conexeu Sciences Inc
NAICS : 541714
SIC : 2834
ISIN : US20715F1003
Description
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.88 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.89 | |||||
Quick Ratio | 7.89 | |||||
Cash Ratio | 6.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -56.46 | |||||
ROA % | -51.16 | |||||
ROIC % | -278.71 | |||||
ROC (Joel Greenblatt) % | -1956.08 | |||||
ROCE % | -56.46 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 22.01 | |||||
Price-to-Tangible-Book | 22.01 | |||||
EV-to-EBIT | -49.73 | |||||
EV-to-EBITDA | -49.95 | |||||
EV-to-FCF | -59.27 | |||||
| Price-to-Net-Current-Asset-Value | 22.68 | |||||
| Price-to-Net-Cash | 26.73 | |||||
Earnings Yield (Greenblatt) % | -2.01 | |||||
FCF Yield % | -1.69 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CNXU
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Conexeu Sciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.192 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 42.4 | ||
| 14-Day ATR ($) | 1.387659 | ||
| 20-Day SMA ($) | 8.988 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 7.1001 - 18.7915 | ||
| Shares Outstanding (Mil) | 26.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Conexeu Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Conexeu Sciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Conexeu Sciences Inc Frequently Asked Questions
What is Conexeu Sciences Inc(CNXU)'s stock price today?
The current price of CNXU is $7.48. The 52 week high of CNXU is $18.79 and 52 week low is $7.10.
When is next earnings date of Conexeu Sciences Inc(CNXU)?
The next earnings date of Conexeu Sciences Inc(CNXU) is .
Does Conexeu Sciences Inc(CNXU) pay dividends? If so, how much?
Conexeu Sciences Inc(CNXU) does not pay dividend.
Guru Commentaries on NAS:CNXU
No articles.
Press Release
Articles on Conexeu Sciences Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers